Short description
Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.
Description
Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Waltham, Massachusetts, United States, North America
Founded on
January 1, 2007
Exited on
April 24, 2017
Went public on
April 24, 2017
Stock symbol
VRDN
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, Noaccessforu, Noway Youcantaccess, Nopepepe, Nopepepe, Nopepepe, Nopepepe, Noaccess, Noway Youcantaccess, Nopepepe, No Way, Noaccess
Sign in for full access
Founders
Eric Newell Olson, William Marshall